These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29751003)

  • 1. SATB1 in Malignant T Cells.
    Fredholm S; Willerslev-Olsen A; Met Ö; Kubat L; Gluud M; Mathiasen SL; Friese C; Blümel E; Petersen DL; Hu T; Nastasi C; Lindahl LM; Buus TB; Krejsgaard T; Wasik MA; Kopp KL; Koralov SB; Persson JL; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Becker JC; Ødum N
    J Invest Dermatol; 2018 Aug; 138(8):1805-1815. PubMed ID: 29751003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
    Gao Y; Liu F; Sun J; Wen Y; Tu P; Kadin ME; Wang Y
    J Invest Dermatol; 2021 Mar; 141(3):607-618.e6. PubMed ID: 32771472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
    Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
    Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
    Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA in mycosis fungoides and skin inflammation.
    Persson JL
    APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
    Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SATB1 Is a Pivotal Epigenetic Biomarker in Cutaneous T-Cell Lymphomas.
    Poglio S; Merlio JP
    J Invest Dermatol; 2018 Aug; 138(8):1694-1696. PubMed ID: 30032787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB1 Defines a Subtype of Cutaneous CD30
    Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
    J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal changes and functional alterations of T-cell substates gene expression during the progression of mycosis fungoides.
    Dong Z; Zhu X; Pan X; Su Q; Wang F
    Arch Dermatol Res; 2024 May; 316(6):207. PubMed ID: 38787417
    [No Abstract]   [Full Text] [Related]  

  • 10. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
    Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
    Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides.
    Örnek S; Ozekinci S; Ipin T; Kocaturk E
    J Cutan Pathol; 2024 Mar; 51(3):232-238. PubMed ID: 37932931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomes.
    Zhang Y; Wu XH; Luo CL; Zhang JM; He BC; Chen G
    Int J Mol Med; 2010 May; 25(5):695-700. PubMed ID: 20372811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.
    Krejsgaard T; Ralfkiaer U; Clasen-Linde E; Eriksen KW; Kopp KL; Bonefeld CM; Geisler C; Dabelsteen S; Wasik MA; Ralfkiaer E; Woetmann A; Odum N
    J Invest Dermatol; 2011 Jun; 131(6):1331-8. PubMed ID: 21346774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation.
    Ahlfors H; Limaye A; Elo LL; Tuomela S; Burute M; Gottimukkala KV; Notani D; Rasool O; Galande S; Lahesmaa R
    Blood; 2010 Sep; 116(9):1443-53. PubMed ID: 20522714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
    Kopp KL; Ralfkiaer U; Gjerdrum LM; Helvad R; Pedersen IH; Litman T; Jønson L; Hagedorn PH; Krejsgaard T; Gniadecki R; Bonefeld CM; Skov L; Geisler C; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Cell Cycle; 2013 Jun; 12(12):1939-47. PubMed ID: 23676217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice.
    Harro CM; Perez-Sanz J; Costich TL; Payne KK; Anadon CM; Chaurio RA; Biswas S; Mandal G; Rigolizzo KE; Sprenger KB; Mine JA; Showe LC; Yu X; Liu K; Rodriguez PC; Pinilla-Ibarz J; Sokol L; Conejo-Garcia JR
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33270606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.
    Ehrentraut S; Schneider B; Nagel S; Pommerenke C; Quentmeier H; Geffers R; Feist M; Kaufmann M; Meyer C; Kadin ME; Drexler HG; MacLeod RA
    Oncotarget; 2016 Jun; 7(23):34201-16. PubMed ID: 27144517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.
    Lauenborg B; Christensen L; Ralfkiaer U; Kopp KL; Jønson L; Dabelsteen S; Bonefeld CM; Geisler C; Gjerdrum LM; Zhang Q; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Oncotarget; 2015 Jun; 6(17):15235-49. PubMed ID: 25915535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21.
    Wang Y; Gu X; Zhang G; Wang L; Wang T; Zhao Y; Zhang X; Zhou Y; Kadin M; Tu P
    Blood; 2014 May; 123(22):3452-61. PubMed ID: 24747435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.